As the European markets, including France's CAC 40 Index, show modest gains amid hopes for economic stimulus and potential interest rate cuts from the European Central Bank, investors are increasingly focused on companies with strong growth prospects and significant insider ownership. In this context, identifying growth companies listed on Euronext Paris with up to 15% insider ownership can be a strategic move, as such stocks may benefit from aligned interests between management and shareholders in navigating current market conditions.
Top 10 Growth Companies With High Insider Ownership In France
Overview: Exclusive Networks SA is a global cybersecurity specialist focused on digital infrastructure, with a market cap of €2.14 billion.
Operations: The company generates revenue from its operations across various regions, with €480 million from APAC, €4.19 billion from EMEA, and €705 million from the Americas.
Insider Ownership: 13.1%
Exclusive Networks is poised for significant earnings growth, forecast at 33.5% annually, outpacing the French market. Despite a dip in profit margins from 5.5% to 2.7%, its revenue growth of 13.1% remains robust compared to the wider market's 5.6%. Insider ownership is substantial, with Permira and founder Olivier Breittmayer holding a majority stake of 66.7%. A proposed €2.2 billion buyout by Clayton, Dubilier & Rice and Permira could privatize the company, offering a premium on current share prices while refinancing existing debt.
Overview: MedinCell S.A. is a pharmaceutical company based in France that specializes in developing long-acting injectables across various therapeutic areas, with a market cap of €446.20 million.
Operations: The company's revenue is primarily derived from its Pharmaceuticals segment, totaling €11.95 million.
Insider Ownership: 15.8%
MedinCell is experiencing rapid growth, with expected revenue increases of 46.2% annually, significantly outpacing the French market. The company recently secured a strategic alliance with AbbVie, potentially unlocking up to $1.9 billion in milestones and royalties from multiple therapeutic products. Insider ownership remains strong amidst these developments, and MedinCell's innovative BEPO® technology has already led to FDA approval for UZEDY®, reinforcing its growth trajectory despite negative shareholders' equity challenges.
Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions with a market cap of approximately €1.36 billion.
Operations: OVH Groupe S.A. generates revenue from its Public Cloud (€169.01 million), Private Cloud (€589.61 million), and Web Cloud & Other services (€185.43 million).
Insider Ownership: 10.5%
OVH Groupe is positioned for significant growth, with revenue expected to increase by 9.7% annually, surpassing the French market's average. Despite a volatile share price recently, OVH is forecast to achieve profitability within three years, indicating robust potential. The stock trades at 41.3% below its estimated fair value, suggesting it could be undervalued. Recent participation in the OCP Global Summit highlights its active engagement in industry developments and strategic visibility efforts globally.
Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include ENXTPA:EXN ENXTPA:MEDCL and ENXTPA:OVH.
